Meconium Aspiration – Causes, Symptoms & Treatment
Meconium aspiration refers to the inhalation of meconium (first newborn stool) into the lungs of a newborn, which can cause serious respiratory complications.
Things worth knowing about "Meconium aspiration"
Meconium aspiration refers to the inhalation of meconium (first newborn stool) into the lungs of a newborn, which can cause serious respiratory complications.
What is Meconium Aspiration?
Meconium aspiration occurs when a newborn inhales meconium – the thick, dark green substance that forms the first bowel movement of a newborn – into the airways and lungs. When meconium passes into the amniotic fluid before or during delivery, the infant may breathe it in, leading to a potentially life-threatening condition known as Meconium Aspiration Syndrome (MAS).
Causes
Meconium is normally retained in the intestine of the fetus and expelled after birth. Under conditions of stress or oxygen deprivation, it may be released into the amniotic fluid prematurely. Common causes and risk factors include:
- Fetal hypoxia (oxygen deprivation) during labor or delivery
- Post-term pregnancy (beyond 42 weeks of gestation)
- Umbilical cord complications such as cord prolapse or entanglement
- Placental insufficiency (inadequate fetal nourishment via the placenta)
- Maternal conditions such as preeclampsia or diabetes
- Prolonged or difficult labor
Symptoms
The severity of symptoms in meconium aspiration depends on the amount of meconium inhaled and the degree of lung injury. Common signs include:
- Greenish or brownish discoloration of amniotic fluid at birth
- Breathing difficulties (dyspnea), rapid or labored breathing
- Bluish discoloration of the skin (cyanosis)
- Barrel-shaped, overinflated chest
- Low Apgar scores at birth
- In severe cases: pulmonary hypertension (elevated blood pressure in the lungs)
Diagnosis
Diagnosis is established through clinical evaluation and diagnostic tests:
- Clinical assessment: History of meconium-stained amniotic fluid and respiratory distress in the newborn
- Chest X-ray: Typical findings include patchy infiltrates and areas of atelectasis (collapsed lung segments)
- Blood gas analysis: Detection of low oxygen and elevated carbon dioxide levels in the blood
- Pulse oximetry: Continuous monitoring of oxygen saturation
- Echocardiography: To assess pulmonary hypertension if suspected
Treatment
Treatment is tailored to the severity of the condition and is typically administered in a neonatal intensive care unit (NICU):
Immediate Delivery Room Management
- Suctioning of meconium from the mouth and nose immediately after birth
- Resuscitation measures as needed, including ventilation and chest compressions
Supportive and Intensive Care
- Supplemental oxygen or mechanical ventilation for severe respiratory failure
- Surfactant therapy: Administration of a surface-active agent to improve lung expansion
- Inhaled nitric oxide (iNO): To treat pulmonary hypertension
- Extracorporeal membrane oxygenation (ECMO): Reserved for the most severe cases as a last resort
- Antibiotics if a secondary infection is suspected
- Temperature regulation and fluid management
Prognosis
The outlook depends largely on the severity of aspiration and the extent of oxygen deprivation. Mild cases often recover fully without lasting consequences. Severe cases may result in long-term respiratory problems, neurological impairment, or, in rare instances, death. Advances in neonatal intensive care have significantly improved survival rates over recent decades.
References
- Wiswell TE, Gannon CM, Jacob J et al. - Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics. 2000;105(1):1-7.
- World Health Organization (WHO) - Guidelines on Basic Newborn Resuscitation. Geneva: WHO Press, 2012.
- Gomella TL, Eyal FG, Bany-Mohammed F - Gomella's Neonatology: Management, Procedures, On-Call Problems, Diseases, and Drugs. 8th ed. McGraw-Hill Education, 2020.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.